Oxford Immunotec Global PLC | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.61 |
Market Cap |
$368.46 M |
Shares Outstanding |
26.62 M |
Public Float |
23.89 M |
Address |
Milton Park Abingdon Oxfordshire OX14 4RZ United Kingdom |
Employees | - |
Website | http://oxfordimmunotec.com |
Updated | 07/08/2019 |
Oxford Immunotec Global Plc operates as a medical diagnostics company, which develops and commercializes proprietary tests for under-served immune-regulated conditions. Its current product lines and development activities principally focus on four areas: infectious diseases, transplantation, autoimmune and inflammatory disease and immune-oncology. Its products include T-SPOT. |